Wise Christopher L, Dall Bruce E
Carolinas Medical Center, Department of Orthopedic Surgery, Charlotte, NC, USA.
J Spinal Disord Tech. 2008 Dec;21(8):579-84. doi: 10.1097/BSD.0b013e31815ecc4b.
Prospective cohort.
Comparing efficacy and outcomes of a new technique for sacroiliac arthrodesis.
The sacroiliac joint has been described as a possible source of chronic low back pain. However, surgical treatment of sacroiliac pain and dysfunction is controversial. Arthrodesis is normally reserved as a salvage procedure when all others have failed to relieve pain and involves an extensive surgical exposure. We have developed a novel technique of sacroiliac arthrodesis using percutaneously inserted fusion cages filled with bone morphogenic protein. This study describes the radiographic and clinical outcomes of this procedure.
Thirteen consecutive patients underwent minimally invasive sacroiliac arthrodesis between February and December 2004 at a single teaching hospital and were prospectively followed. Six patients had bilateral fusions for a total of 19 joints. The average age was 53.1 (range 45 to 62). Average body mass index was 31.2 (range 21.9 to 46.9). Mean follow-up was 29.5 months (range 24 to 35). Diagnosis was confirmed using fluoroscopically guided intra-articular injections of local anesthetic and corticosteroid when their pain was relieved 2 or more hours. Arthrodesis was only performed on patients with positive injections who subsequently had their symptoms recur. Outcome measurements included radiographic assessment for fusion and improvement in visual analog pain scale for low back pain, leg pain, and dyspareunia. Computed tomography scan to evaluate implant placement was performed postoperatively and again at 6 months to assess fusion.
The overall fusion rate was 89% (17/19 joints). Significant improvements were seen in final low back pain score on a visual analog scale (0 to 10) (average improvement 4.9, P< or =0.001). Leg pain improved an average of 2.4 (P=0.013). Dyspareunia improved an average of 2.6 (P=0.0028). One patient was revised to an open arthrodesis secondary to nonunion and persistent pain. There were no infections or neurovascular complications.
Minimally invasive sacroiliac arthrodesis via a percutaneous posterior approach is a safe and efficacious procedure, leading to a high fusion rate and significant improvement in low back, leg pain, and dyspareunia.
前瞻性队列研究。
比较一种骶髂关节融合新技术的疗效和结果。
骶髂关节被认为可能是慢性下腰痛的一个来源。然而,骶髂关节疼痛和功能障碍的外科治疗存在争议。当所有其他方法都无法缓解疼痛时,关节融合术通常作为一种挽救性手术,且需要广泛的手术暴露。我们开发了一种新型的骶髂关节融合技术,使用经皮插入的填充骨形态发生蛋白的融合器。本研究描述了该手术的影像学和临床结果。
2004年2月至12月期间,在一家教学医院,13例连续患者接受了微创骶髂关节融合术,并进行前瞻性随访。6例患者进行了双侧融合,共19个关节。平均年龄为53.1岁(范围45至62岁)。平均体重指数为31.2(范围21.9至46.9)。平均随访时间为29.5个月(范围24至35个月)。当患者疼痛缓解2小时或更长时间时,通过荧光透视引导下关节内注射局部麻醉剂和皮质类固醇来确诊。仅对注射阳性且随后症状复发的患者进行关节融合术。结果测量包括融合的影像学评估以及下腰痛、腿痛和性交困难的视觉模拟疼痛量表的改善情况。术后进行计算机断层扫描以评估植入物位置,并在6个月时再次进行扫描以评估融合情况。
总体融合率为89%(17/19个关节)。在视觉模拟量表(0至10)上,最终下腰痛评分有显著改善(平均改善4.9,P≤0.001)。腿痛平均改善2.4(P = 0.013)。性交困难平均改善2.6(P = 0.0028)。1例患者因不愈合和持续疼痛而改为开放性关节融合术。无感染或神经血管并发症。
经皮后路微创骶髂关节融合术是一种安全有效的手术,融合率高,能显著改善下腰痛、腿痛和性交困难。